Skip to content
Study details
Enrolling now

Early Feasibility Study of Cartilage Defect Repair

Cytex Therapeutics, Inc.
NCT IDNCT06823089ClinicalTrials.gov data as of Apr 2026
Target enrollment

15

Study length

about 6 years

Ages

14–64

Locations

1 site in MO

What this study is about

Researchers are testing a new device called the ReNew Hip Implant for people with hip problems that have damaged cartilage. The trial will last about 2 years and involve up to 15 participants who are at least 14 years old and need surgery to repair their hips.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use ReNew Hip Implant

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: To establish initial safety (adverse events and device related serious adverse events) and effectiveness (pain and function) of the ReNew Hip Implant

Secondary: Patient Reported Outcome Measures, Radiographic

Devices

implantable

Body systems

Musculoskeletal